Displaying 1 - 20 of 165 results
Released Company Title Industry Topic
19 Oct 2020
08:00 CEST
QUANTUM GENOMICS Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Qilu Pharmaceutical 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
19 Oct 2020
08:00 CEST
QUANTUM GENOMICS Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Qilu Pharmaceutical 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
14 Oct 2020
18:00 CEST
QUANTUM GENOMICS 2020 Half-year financial report 20103010 Biotechnology Legal
01 Oct 2020
18:00 CEST
QUANTUM GENOMICS Rapport financier semestriel au 30 juin 2020 20103010 Biotechnology Legal
01 Oct 2020
18:00 CEST
QUANTUM GENOMICS Quantum Genomics publie ses résultats du premier semestre 2020 et fait le point sur son activité 20103010 Biotechnology Sales, Income, Commercial results
22 Sep 2020
18:00 CEST
QUANTUM GENOMICS Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Orient EuroPharma (OEP) 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
22 Sep 2020
18:00 CEST
QUANTUM GENOMICS Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Orient EuroPharma (OEP) 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
02 Sep 2020
18:00 CEST
QUANTUM GENOMICS Informations sur le contrat de financement avec Negma Group Ltd 20103010 Biotechnology Other subject
13 Jul 2020
08:00 CEST
QUANTUM GENOMICS Quantum Genomics annonce le recrutement du premier patient dans l'étude FRESH, son étude pivot de phase III dans l'Hypertension Artérielle Difficile à Traiter/Résistante 20103010 Biotechnology Other subject
13 Jul 2020
08:00 CEST
QUANTUM GENOMICS Quantum Genomics Enrolls First Patient in Its Pivotal Phase III FRESH Trial of Firibastat in Difficult-to-treat and Resistant Hypertension 20103010 Biotechnology Other subject
07 Jul 2020
18:00 CEST
QUANTUM GENOMICS Bilan semestriel du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont 20103010 Biotechnology Other subject
06 May 2020
18:00 CEST
QUANTUM GENOMICS Quantum Genomics Announces Interim Analysis from Study of Firibastat in Renal Failure Patients Biotechnology Other subject
06 May 2020
18:00 CEST
QUANTUM GENOMICS Quantum Genomics annonce les résultats de l'analyse intermédiaire de l'étude du Firibastat chez les patients insuffisants rénaux Biotechnology Other subject
07 Apr 2020
18:00 CEST
QUANTUM GENOMICS Quantum Genomics Provides Update on the Impact of the COVID-19 Health Crisis on Clinical Research Activities Biotechnology Other subject
07 Apr 2020
18:00 CEST
QUANTUM GENOMICS Information sur l'impact de la crise sanitaire - Covid 19 sur les activités de recherche clinique Biotechnology Other subject
26 Mar 2020
18:35 CET
QUANTUM GENOMICS 2019 annual report (french only) Biotechnology Legal
26 Mar 2020
18:30 CET
QUANTUM GENOMICS Rapport financier annuel 2019 Biotechnology Legal
26 Mar 2020
18:15 CET
QUANTUM GENOMICS Quantum Genomics Secured New Financing, Published its Financial Statements for Fiscal Year 2019 and Provides 2019 Highlights Biotechnology Sales, Income, Commercial results
26 Mar 2020
18:15 CET
QUANTUM GENOMICS Quantum Genomics réussit la mise en place d'un nouveau financement, publie ses résultats financiers de l'exercice 2019 et fait le point sur son activité Biotechnology Sales, Income, Commercial results
28 Jan 2020
07:30 CET
QUANTUM GENOMICS Quantum Genomics Appoints Benoît Gueugnon as Vice President of Finance Biotechnology Other subject